Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2011 2
2012 1
2014 1
2015 1
2016 1
2018 3
2019 1
2020 4
2021 6
2022 6
2023 5
2024 8
2025 1
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial.
Bauer A, Schreinlechner M, Sappler N, Dolejsi T, Tilg H, Aulinger BA, Weiss G, Bellmann-Weiler R, Adolf C, Wolf D, Pirklbauer M, Graziadei I, Gänzer H, von Bary C, May AE, Wöll E, von Scheidt W, Rassaf T, Duerschmied D, Brenner C, Kääb S, Metzler B, Joannidis M, Kain HU, Kaiser N, Schwinger R, Witzenbichler B, Alber H, Straube F, Hartmann N, Achenbach S, von Bergwelt-Baildon M, von Stülpnagel L, Schoenherr S, Forer L, Embacher-Aichhorn S, Mansmann U, Rizas KD, Massberg S; ACEI-COVID investigators. Bauer A, et al. Among authors: pirklbauer m. Lancet Respir Med. 2021 Aug;9(8):863-872. doi: 10.1016/S2213-2600(21)00214-9. Epub 2021 Jun 11. Lancet Respir Med. 2021. PMID: 34126053 Free PMC article. Clinical Trial.
Editorial: Personalized medicine in CKD patients.
Eisenga MF, Mayer G, Pirklbauer M, Provenzano M. Eisenga MF, et al. Among authors: pirklbauer m. Front Nephrol. 2023 Aug 16;3:1270382. doi: 10.3389/fneph.2023.1270382. eCollection 2023. Front Nephrol. 2023. PMID: 37675370 Free PMC article. No abstract available.
Editorial: Insights in clinical research in nephrology.
Provenzano M, Borelli G, Pirklbauer M, Mayer G. Provenzano M, et al. Among authors: pirklbauer m. Front Nephrol. 2024 Jul 24;4:1441190. doi: 10.3389/fneph.2024.1441190. eCollection 2024. Front Nephrol. 2024. PMID: 39113728 Free PMC article. No abstract available.
Anti-inflammatory potential of Empagliflozin.
Pirklbauer M. Pirklbauer M. Inflammopharmacology. 2021 Apr;29(2):573-576. doi: 10.1007/s10787-021-00797-9. Epub 2021 Mar 17. Inflammopharmacology. 2021. PMID: 33728540 Free PMC article. No abstract available.
Research update for articles published in EJCI in 2016.
Adlbrecht C, Blanco-Verea A, Bouzas-Mosquera MC, Brion M, Burtscher M, Carbone F, Chang TT, Charmandari E, Chen JW, Correia-Costa L, Dullaart RPF, Eleftheriades M, Fernandez-Fernandez B, Goliasch G, Gremmel T, Groeneveld ME, Henrique A, Huelsmann M, Jung C, Lichtenauer M, Montecucco F, Nicolaides NC, Niessner A, Palmeira C, Pirklbauer M, Sanchez-Niño MD, Sotiriadis A, Sousa T, Sulzgruber P, van Beek AP, Veronese N, Winter MP, Yeung KK, Bouzas-Mosquera A. Adlbrecht C, et al. Among authors: pirklbauer m. Eur J Clin Invest. 2018 Oct;48(10):e13016. doi: 10.1111/eci.13016. Epub 2018 Sep 16. Eur J Clin Invest. 2018. PMID: 30099749 Review. No abstract available.
40 results